ENTRY       D00250                      Drug
NAME        Capsaicin (JAN/USP);
            Zostrix (TN)
PRODUCT     QUTENZA (Averitas Pharma)
FORMULA     C18H27NO3
EXACT_MASS  305.1991
MOL_WEIGHT  305.4119
CLASS       Neuropsychiatric agent
             DG02030  Anesthetics
              DG01675  Local anesthetic
REMARK      Same as: C06866
            ATC code: M02AB01 N01BX04
            Product: D00250<US>
EFFICACY    Analgesic (topical), Transient receptor potential (TRP) channel agonist
COMMENT     Antineuralgic, specific pain syndromes, topical
TARGET      TRPV1 [HSA:7442] [KO:K05222]
  PATHWAY   hsa04080(7442)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
               M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
                M02AB Capsaicin and similar agents
                 M02AB01 Capsaicin
                  D00250  Capsaicin (JAN/USP) &lt;US&gt;
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BX Other local anesthetics
                 N01BX04 Capsaicin
                  D00250  Capsaicin (JAN/USP) &lt;US&gt;
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Inorganic and organic chemicals
               Capsaicin
                D00250  Capsaicin (JAN/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG01675  Local anesthetic
                D00250  Capsaicin
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Transient receptor potential channels
                TRPV1
                 D00250  Capsaicin (JAN/USP) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00250
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00250
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00250
DBLINKS     CAS: 404-86-4
            PubChem: 7847316
            ChEBI: 3374
            PDB-CCD: 4DY
            LigandBox: D00250
            NIKKAJI: J1.529F
ATOM        22
            1   C8y C    14.3789  -14.5250
            2   C8x C    13.1676  -15.2238
            3   C8x C    14.3789  -13.1272
            4   C1b C    15.5904  -15.2238
            5   C8y C    11.9504  -14.5250
            6   C8x C    13.1676  -12.4226
            7   N1b N    16.8017  -14.5250
            8   C8y C    11.9504  -13.1272
            9   O2a O    10.7391  -15.2238
            10  C5a C    18.0189  -15.2179
            11  O1a O    10.7391  -12.4226
            12  C1a C     9.5219  -14.5307
            13  C1b C    19.2244  -14.5250
            14  O5a O    18.0189  -16.6216
            15  C1b C    20.4357  -15.2179
            16  C1b C    21.6529  -14.5190
            17  C1b C    22.8644  -15.2179
            18  C2b C    24.0816  -14.5190
            19  C2b C    25.2929  -15.2179
            20  C1c C    26.5042  -14.5190
            21  C1a C    27.7214  -15.2122
            22  C1a C    26.5042  -13.1156
BOND        22
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     5   9 1
            9     7  10 1
            10    8  11 1
            11    9  12 1
            12   10  13 1
            13   10  14 2
            14   13  15 1
            15   15  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 2
            19   19  20 1
            20   20  21 1
            21   20  22 1
            22    6   8 1
///
